The invention relates to an autologous cancer vaccine, and to a method of producing same, comprising the following steps: a) extracting proteins from a serum or plasma sample obtained from a cancer patient； and b) bringing the proteins extracted in step a) into contact with particles of hydroxyapatite and/or tricalcium phosphate.
